Navamedic ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	504	571	454	637	601	556
Market Cap Growth	14.05%	25.74%	-28.72%	5.92%	8.19%	90.28%
Enterprise Value	638	831	534	720	625	561
Last Close Price	21.00	23.80	25.27	36.09	34.32	33.43
PE Ratio	-	-	-	-	20.43	899.28
PS Ratio	0.89	1.01	0.85	1.24	1.57	2.00
PB Ratio	1.51	1.71	2.10	3.10	2.87	3.68
P/TBV Ratio	-	-	-	-	7.67	8.84
P/FCF Ratio	-	23.59	12.60	-	38.32	-
P/OCF Ratio	20.82	23.59	11.54	292.27	33.51	-
EV/Sales Ratio	1.13	1.47	1.01	1.41	1.64	2.02
EV/EBITDA Ratio	13.39	17.45	12.30	14.65	12.60	34.77
EV/EBIT Ratio	39.23	51.11	16.81	18.17	14.07	49.01
EV/FCF Ratio	-	34.34	14.83	-	39.84	-
Debt / Equity Ratio	0.62	0.62	0.55	0.74	0.28	0.31
Debt / EBITDA Ratio	4.37	4.37	2.55	2.96	1.14	2.57
Debt / FCF Ratio	8.61	8.61	3.29	-	3.74	-
Net Debt / Equity Ratio	0.40	0.40	0.38	0.56	0.02	-0.04
Net Debt / EBITDA Ratio	2.82	2.82	1.87	2.34	0.07	-0.37
Net Debt / FCF Ratio	5.54	5.54	2.26	-6045.00	0.22	2.96
Asset Turnover	0.94	0.94	1.09	1.15	1.07	0.94
Inventory Turnover	3.48	3.48	3.48	3.39	3.09	3.21
Quick Ratio	0.83	0.83	0.66	0.49	0.90	0.78
Current Ratio	1.55	1.55	1.42	1.11	1.93	1.51
Return on Equity (ROE)	-8.55%	-8.55%	-2.60%	-6.59%	16.31%	0.44%
Return on Assets (ROA)	1.68%	1.68%	4.08%	5.57%	7.79%	2.43%
Return on Invested Capital (ROIC)	3.47%	4.24%	10.29%	14.86%	17.17%	2.33%
Return on Capital Employed (ROCE)	2.90%	2.90%	9.70%	12.50%	17.30%	5.90%
Earnings Yield	-4.67%	-4.12%	-1.21%	-2.15%	4.90%	0.11%
FCF Yield	-	4.24%	7.94%	-0.00%	2.61%	-0.36%
Buyback Yield / Dilution	-	-	-1.24%	-1.48%	-3.60%	-13.61%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.